Insider: Baroldi Joseph EVP, Chief Business Officer - IONIS PHARMACEUTICALS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 31,926 | 3,071 | 34,997 |
| Value | $2,044,860.30 | $196,697.55 | $2,241,557.85 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/09/2025 | DDS | 11,950 | Direct | COM | $62.16 | $742,838.29 | 31,926 |
| 09/05/2025 | DDS | 250 | Direct | COM | $62.00 | $15,500.00 | 31,926 |
| 09/03/2025 | DDS | 2,800 | Direct | COM | $62.01 | $173,628.28 | 31,926 |
| 09/03/2025 | DDS | 30,000 | Direct | COM | $59.09 | $1,772,592.00 | 16,926 |
| 04/16/2025 | DDS | 3,928 | Direct | COM | $28.40 | $111,555.20 | 31,926 |
| 01/16/2025 | DDS | 3,401 | Direct | COM | $32.70 | $111,212.70 | 25,017 |
| 01/16/2025 | DDS | 1,029 | Indirect | COM | $32.70 | $33,648.30 | 3,071 |
| 04/16/2024 | DDS | 4,006 | Direct | COM | $41.60 | $166,640.79 | 19,631 |
| 01/17/2024 | DDS | 1,460 | Direct | COM | $50.42 | $73,608.82 | 12,799 |
| 01/17/2024 | DDS | 564 | Indirect | COM | $50.42 | $28,435.19 | 1,640 |
| 04/18/2023 | DDS | 3,880 | Direct | COM | $36.50 | $141,630.86 | 10,571 |
| 01/18/2023 | DDS | 375 | Indirect | COM | $39.79 | $14,920.05 | 851 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research